A TritonX-100-split virion influenza vaccine is safe and fulfills the Committee for Proprietary Medicinal Products (CPMP) recommendations for the European community for immunogenicity, in children, adults and the elderly

Biologicals

Volumn 28, Issue 2, 2000, Pages 95-103

  Lina, Bruno ^a   Fletcher, Mark A ^b   Valette, Martine ^a   Saliou, Pierre ^b   Aymard, Michèle ^a  

^a UNIVERSITÉ LYON 1   (France)

^b SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; TRITON X 100;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; FEVER; HUMAN; IMMUNOGENICITY; INFLAMMATION; INFLUENZA; INFLUENZA VACCINATION; INJECTION PAIN; INJECTION SITE; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; QUALITY CONTROL; SCHOOL CHILD; SEASONAL VARIATION; SEROCONVERSION; VIRION; VIRUS STRAIN;

INFLUENZA VIRUS; RNA VIRUSES;

EID: 0033759379     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2000.0245     Document Type: Article

References (29)

1. Epidemiology of influenza in man
2. Influenza: Virology, epidemiology, disease, and prevention
3. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
4. Epidemiology of viral infections and evaluation of the potential benefit of OM·85 BV on the virologic status of children attending day-care centers
5. The effectiveness of vaccination against Influenza in healthy, working adults
6. Protection against influenza after annually repeated vaccination - A meta-analysis of serologic and field studies
7. The plea against annual influenza vaccination? 'The Hoskins' Paradox' revisited
8. Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults
9. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly
10. Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus
11. Disruption of influenza virus A by diethylether·Tween and tri-N·butyl phosphate-Tween mixtures
12. Comparison of new triton X-100- and tween-ether-treated split-product vaccines in children
13. Evaluation of adverse events after influenza vaccination in hospital personnel
14. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial
15. Adverse reactions to influenza vaccine in elderly people: Randomised double blind placebo controlled trial
16. Antibody induction by influenza vaccines in the elderly: A review of the literature
17. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: Antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response
18. Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection
19. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age
20. Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: Effects of aging and 'original antigenic sin'
21. Antibody response after influenza immunization with various vaccine doses: A double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers
22. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial
23. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine
24. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine
25. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial